Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetic Foot Ulcers (DFUs)Venous Leg Ulcers (VLUs)Pressure UlcersSurgical Wound Dehiscence (SWD)Chronic WoundsUndermined and Tunneling Wounds
Interventions
DEVICE

Acellular Porcine-Derived Wound Matrix

This intervention is a sterile, acellular, three-dimensional biologic scaffold derived from porcine liver tissue using a proprietary perfusion decellularization and drying process. It retains the native extracellular matrix structure and supports tissue granulation and healing in complex wounds. Miro3D is applied topically to the debrided wound bed and rehydrated prior to use. It is indicated for use in a range of chronic and complex wounds, including diabetic foot ulcers, venous leg ulcers, pressure injuries, and surgical dehiscence. In this study, it is administered in an outpatient setting alongside standard of care treatments.

Trial Locations (1)

33321

RECRUITING

Barry University Clinical Research, Tamarac

All Listed Sponsors
lead

Reprise Biomedical, Inc.

INDUSTRY